CIK 0001590560
- Large accelerated filer
uniQure N.V.
Sign in to watch- Ticker
- QURE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 339-970-7000
- Business address
- PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
- Former names
- uniQure B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $192,950
- in 1 filing, $193K under 10b5-1 plans
Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-25 | KLEMT CHRISTIAN Chief Financial Officer | Sale | −14,341 | $10.70 | $153K | 152,372 |
| 2024-12-10 | Kapusta Matthew C CEO, Managing Director | Exercise or conversion 10b5-1 | +100,000 | $14.71 | $1.5M | 697,915 |
| 2024-12-10 | Kapusta Matthew C CEO, Managing Director | Sale 10b5-1 | −100,000 | $15.03 | $1.5M | 597,915 |
| 2024-12-10 | Kapusta Matthew C CEO, Managing Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −100,000 | 0 | ||
| 2024-12-09 | Kapusta Matthew C CEO, Managing Director | Sale | −3,418 | $7.63 | $26K | 597,915 |
| 2024-12-09 | KLEMT CHRISTIAN Chief Financial Officer | Sale | −1,796 | $7.55 | $14K | 166,713 |
| 2024-12-08 | Kapusta Matthew C CEO, Managing Director | Grant or award | +10,494 | 601,333 | ||
| 2024-12-08 | KLEMT CHRISTIAN Chief Financial Officer | Grant or award | +3,672 | 168,509 | ||
| 2024-06-26 | Abi-Saab Walid Chief Medical Officer | Sale | −1,447 | $4.36 | $6K | 115,253 |
| 2024-06-19 | Gut Robert Director | Grant or award | +8,080 | 52,245 | ||
| 2024-06-19 | Gut Robert Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-19 | Springhorn Jeremy P. Director | Grant or award | +8,080 | 31,836 | ||
| 2024-06-19 | Springhorn Jeremy P. Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-19 | Meek David D. Director | Grant or award | +8,080 | 28,332 | ||
| 2024-06-19 | Meek David D. Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-19 | Balachandran Madhavan Director | Grant or award | +8,080 | 31,839 | ||
| 2024-06-19 | Balachandran Madhavan Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-19 | Kaye Jack Director | Grant or award | +8,080 | 14,581 | ||
| 2024-06-19 | Kaye Jack Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-19 | POST LEONARD E Director | Grant or award | +8,080 | 24,079 |
Page 10 of 13 · 251 trades